7 results
·
23ms
·
Sources: EU EUDAMED, US FDA
ZywieZ3 Sensor & Adhesive
FDA 510(k)
FDA Class 2
·Cardiovascular
CT PERFUSION 4
FDA 510(k)
FDA Class 2
·Radiology
Overlapped Compression Therapy
FDA 510(k)
FDA Class 2
·Cardiovascular
PUMP MMT-722NAP PRDGM INS V2.2 PL EN
FDA Adverse Event
Injury
·MEDTRONIC MINIMED·Product code LZG·December 4, 2008
UNICEL DXC 800 SYNCHRON SYSTEM
FDA Adverse Event
Malfunction
·BECKMAN COULTER, INC.·Product code JJE·September 9, 2011
GYNECARE TVT RETROPUBIC SYSTEM
FDA Adverse Event
Injury
·ETHICON SARL·Product code OTN·July 29, 2013
Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias
FDA Enforcement
Class II
·Terminated·Boston Scientific CRM Corp·October 29, 2014